share_log

Novavax | 4: Statement of changes in beneficial ownership of securities-Officer Dubovsky Filip

Novavax | 4: Statement of changes in beneficial ownership of securities-Officer Dubovsky Filip

諾瓦瓦克斯醫藥 | 4:持股變動聲明-高管 Dubovsky Filip
SEC announcement ·  03/13 08:49
牛牛AI助理已提取核心訊息
On March 10, 2024, Novavax's President of R&D, Filip Dubovsky, completed a stock transaction involving the company's common stock. Dubovsky sold 2,597 shares at a price of $5.45 per share, resulting in a total transaction value of $14,153.65. This sale was part of a transaction coded as 'F', typically indicating a payment of exercise price or tax liability by delivering or withholding securities. On the same day, Dubovsky also acquired 5,376 shares through an exercise or conversion of derivative security, coded as 'M'. Following these transactions, Dubovsky's direct holdings in Novavax amounted to 66,613 shares of common stock.
On March 10, 2024, Novavax's President of R&D, Filip Dubovsky, completed a stock transaction involving the company's common stock. Dubovsky sold 2,597 shares at a price of $5.45 per share, resulting in a total transaction value of $14,153.65. This sale was part of a transaction coded as 'F', typically indicating a payment of exercise price or tax liability by delivering or withholding securities. On the same day, Dubovsky also acquired 5,376 shares through an exercise or conversion of derivative security, coded as 'M'. Following these transactions, Dubovsky's direct holdings in Novavax amounted to 66,613 shares of common stock.
2024年3月10日,Novavax的研發總裁菲利普·杜波夫斯基完成了一項涉及公司普通股的股票交易。杜波夫斯基以每股5.45美元的價格出售了2597股股票,總交易價值爲14,153.65美元。此次出售是編碼爲 “F” 的交易的一部分,通常表示通過交付或預扣證券來支付行使價或納稅義務。同一天,杜波夫斯基還通過行使或轉換衍生證券(代號爲 “M”)收購了5,376股股票。這些交易之後,杜波夫斯基在Novavax的直接持有量爲66,613股普通股。
2024年3月10日,Novavax的研發總裁菲利普·杜波夫斯基完成了一項涉及公司普通股的股票交易。杜波夫斯基以每股5.45美元的價格出售了2597股股票,總交易價值爲14,153.65美元。此次出售是編碼爲 “F” 的交易的一部分,通常表示通過交付或預扣證券來支付行使價或納稅義務。同一天,杜波夫斯基還通過行使或轉換衍生證券(代號爲 “M”)收購了5,376股股票。這些交易之後,杜波夫斯基在Novavax的直接持有量爲66,613股普通股。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。